APGE
Apogee Therapeutics·NASDAQ
--
--(--)
--
--(--)
APGE Filings
Filing Date
Form Description
Form Type
2026-04-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-04-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-04-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-04-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-27
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-27 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-27
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-27 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-26
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-26 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-25
Form 8-K - Current report
Key Events
2026-03-25 · Key Events
Form 8-K - Current report
2026-03-25
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-25 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-25
Form 144 - Report of proposed sale of securities
Ownership
2026-03-25 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-23
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-23 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-23
Form 8-K - Current report
Key Events
2026-03-23 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
